South Korea back in stem cell spotlight with new treatment (Reuters)

Reuters – More than five years after South Korea’s scientific reputation was shattered by a cloning research scandal, the country has approved stem cell medication in the form of a treatment for heart attack victims for the world’s first clinical use.